Hear from AccBio Conference keynote speaker Raymond Deshaies about the future of biopharmaceutical development.
Pharmaceutical Engineering & Drug Delivery
Strategies for repurposing existing antiviral drugs, such as modifying how they are dosed, administered, and delivered, could them an important part of fighting COVID-19 until a vaccine is available.
Sytems that interact with cell and tissue barriers in the body are being developed to improve therapeutic delivery and promote healing.
Hear from James about promising career paths in cell-free systems, and get a preview of his upcoming talk at the Cell Free Systems Conference.
The pharmaceutical industry is finding new uses for artificial intelligence (AI) in drug development.
Chemical engineering and polymer science played a significant role in creating this new blood-filtering cancer treatment technology.
The market for chimeric antigen receptor (CAR) T-cell therapy is projected to be valued at almost $300 million by the end of 2018, and this number is expected to grow annually by 32% for the next decade.
Bob Langer of MIT shares his predictions on where he sees the profession of chemical engineering heading over the next 25 years.
Humans have roughly 40 trillion bacterial cells in their bodies; up to 1,000 species of bacteria live in the human gut alone.
This month, brush up on the essentials of continuous evaporation, learn new uses for hydrofoil impellers, enjoy the special section on translational medicine, and more.
Once a non-topic, misfolded and aggregated proteins are drawing a lot of attention, and an article that singles out high-quality publications on these topics is in the spotlight.
New green catalyst draws attention for its speed and efficiency.
A new report released by the European Centre for Disease Prevention and control (ECDC) emphasizes that antimicrobial resistance remains one of the greatest public health threats today.
An international team of researchers has created new antiviral nanoparticles that show potential for outperforming current antiviral drugs.
The device aims to test and predict the effects of biological and chemical agents, diseases, or drugs on the brain without the need for human or animal subjects.
2017 Prausnitz Institute Lecturer Rex Reklaitis speaks with long-time Purdue colleague Dr. Rakesh Agrawal.
In an attempt to find alternatives to conventional recycling, researchers at the Technical University of Munich took inspiration from nature to create a self-disposing supramolecular material with
Microscopic versions of silkworm cocoons that could be used to protect sensitive molecular materials.
The molecular cages show potential for use in energy conversion, drug delivery, and as sensors.
In its first year, BioTM is already topping the charts, with top ratings for viewing, sharing, and discussion of articles.
As we approach ICBE 2017, which begins this weekend in San Diego, we look back at some of the exciting research that figured among 2016's highlights and look forward to the new developments to be unveiled at ICBE 2017.
Researchers at the University of Michigan have had a significant breakthrough in creating a customized therapeutic vaccine for treating colon and melanoma cancer tumors in mice.
This special issue focuses on smart and precision medications, presenting novel work aimed at a wide range of medical applications, from diabetes treatments, cancer therapy, tissue engineering, drug delivery, and more.
Tests by researchers at Baylor College of Medicine have recently shown that nanoparticles modified with polyethylene glycol selectively affect specific areas of the immune system, showing potential
A startup in southern California is designing microbes that extend DNA beyond the natural A, T, G, and C components to include X and Y.
This month, CEP features a Society of Biological Engineering supplement that delves into synthetic biology. The issue also takes a close look at drug-delivery nanoparticles, among many other biological and chemical engineering topics.
The U.S. government announced this week that it is putting aside $55 million to create a public database with health information on about one million volunteers.
Forty healthy volunteers will undergo phase I clinical testing of a Zika DNA vaccine in a few weeks.
One drug company is hoping to collect DNA from 100,000 cancer patients with the goal of matching them with drug companies who could offer the most effective help.
If you could eradicate the Aedes aegypti mosquito responsible for spreading the Zika virus in the Americas, would you? And should you? Those are some of the big questions being tossed about among biologists, ecologists, public health experts, and others today because the technology exists to bid farewell to the pesky mosquito.
The past few years have been full of stories about how a number of serious conditions could be treated or cured by introducing certain bacteria to the digestive system.
Learn about the work Leanne is doing to better understand and improve batteries for use with sustainable energy sources.
The American Institute of Chemical Engineers (AIChE) and its Society for Biological Engineering (SBE), in partnership with John Wiley and Sons, will launch a new quarterly, peer-reviewed, online, o
Researchers at the National University of Singapore (NUS) have discovered that nanodiamonds can be used to effectively deliver chemotherapy drugs and eliminate chemoreisistant cancer cells.
Recent years have brought massive changes in drug delivery, and biological engineers are at the forefront.
This meeting will bring together thought-leaders from the pharmaceutical and biopharmaceutical industries. The meeting's goal is to allow engineers in these industries to assess processes aimed at improving sustainability in their organizations and to both justify their ROI and improve their performance.
One day the capsule you swallow to treat a disease may not deliver medicine but instead may deliver DNA and other biological machinery—essentially a factory that creates medicine on demand.